Correlation Between Vera Therapeutics and X4 Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Vera Therapeutics and X4 Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vera Therapeutics and X4 Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vera Therapeutics and X4 Pharmaceuticals, you can compare the effects of market volatilities on Vera Therapeutics and X4 Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vera Therapeutics with a short position of X4 Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vera Therapeutics and X4 Pharmaceuticals.
Diversification Opportunities for Vera Therapeutics and X4 Pharmaceuticals
-0.53 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Vera and XFOR is -0.53. Overlapping area represents the amount of risk that can be diversified away by holding Vera Therapeutics and X4 Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on X4 Pharmaceuticals and Vera Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vera Therapeutics are associated (or correlated) with X4 Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of X4 Pharmaceuticals has no effect on the direction of Vera Therapeutics i.e., Vera Therapeutics and X4 Pharmaceuticals go up and down completely randomly.
Pair Corralation between Vera Therapeutics and X4 Pharmaceuticals
Given the investment horizon of 90 days Vera Therapeutics is expected to generate 0.38 times more return on investment than X4 Pharmaceuticals. However, Vera Therapeutics is 2.66 times less risky than X4 Pharmaceuticals. It trades about 0.12 of its potential returns per unit of risk. X4 Pharmaceuticals is currently generating about -0.04 per unit of risk. If you would invest 3,840 in Vera Therapeutics on September 4, 2024 and sell it today you would earn a total of 1,115 from holding Vera Therapeutics or generate 29.04% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Vera Therapeutics vs. X4 Pharmaceuticals
Performance |
Timeline |
Vera Therapeutics |
X4 Pharmaceuticals |
Vera Therapeutics and X4 Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Vera Therapeutics and X4 Pharmaceuticals
The main advantage of trading using opposite Vera Therapeutics and X4 Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vera Therapeutics position performs unexpectedly, X4 Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in X4 Pharmaceuticals will offset losses from the drop in X4 Pharmaceuticals' long position.Vera Therapeutics vs. Third Harmonic Bio | Vera Therapeutics vs. Cullinan Oncology LLC | Vera Therapeutics vs. Edgewise Therapeutics | Vera Therapeutics vs. Rallybio Corp |
X4 Pharmaceuticals vs. Candel Therapeutics | X4 Pharmaceuticals vs. Cingulate Warrants | X4 Pharmaceuticals vs. Unicycive Therapeutics | X4 Pharmaceuticals vs. Cardio Diagnostics Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Content Syndication Quickly integrate customizable finance content to your own investment portal |